Navi Mumbai, India

Mahendra Joma Choraghe


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mahendra Joma Choraghe: Innovator in Pharmaceutical Processes

Introduction

Mahendra Joma Choraghe is a notable inventor based in Navi Mumbai, India. With a remarkable portfolio of two patents, he has made significant contributions to the field of pharmaceuticals. His innovations focus on processes that enhance the purity and production efficiency of vital pharmaceutical compounds.

Latest Patents

Choraghe's latest patents showcase his expertise in pharmaceutical processes. The first patent is titled "Process for the preparation of tavaborole," which relates to a method for preparing tavaborole with high purity levels. This invention also includes a method for assessing the purity of tavaborole, making it crucial for quality control in pharmaceutical applications. His second patent, "Process for preparation of alogliptin," outlines a novel process for producing alogliptin, a medication used in diabetes management. These patents highlight Choraghe's commitment to advancing pharmaceutical technologies.

Career Highlights

Throughout his career, Mahendra Joma Choraghe has worked with several prominent companies in the pharmaceutical sector, including Glenmark Life Sciences Limited and Glenmark Pharmaceuticals Limited. His roles in these organizations have allowed him to hone his skills and contribute innovative solutions to complex challenges in the industry.

Collaborations

Choraghe has collaborated with talented professionals such as Samir Naik and Shekhar Bhaskar Bhirud. These collaborations have fostered a creative environment that encourages innovation and drives the development of effective pharmaceutical processes.

Conclusion

Mahendra Joma Choraghe stands as a testament to the power of innovation in the pharmaceutical industry. With his patents focusing on the preparation and assessment of vital compounds like tavaborole and alogliptin, he continues to pave the way for advancements that benefit both the medical community and patients alike. His contributions reflect a commitment to enhancing pharmaceutical processes through innovative thinking and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…